The 11q terminal deletion disorder: A prospective study of 110 cases

被引:207
作者
Grossfeld, PD
Mattina, T
Lai, Z
Favier, R
Jones, KL
Cotter, F
Jones, C
机构
[1] Univ Calif San Diego, Dept Pediat, Div Pediat Cardiol, San Diego, CA 92123 USA
[2] Univ Catania, Dept Pediat, Div Med Genet, Catania, Italy
[3] Hop Enfants Armand Trousseau, Serv Haematol Biol, Paris, France
[4] Univ Calif San Diego, Dept Pediat, Div Dysmorphol, San Diego, CA 92103 USA
[5] Barts & Royal London Sch Med & Dent, Dept Expt Haematol, London, England
关键词
11q terminal deletion disorder; Jacobsen syndrome; partial 11q monosomy; neurocognitive profile; Paris-Trousseau syndrome; thrombocytopenia; hypoplastic left heart syndrome; candidate gene; FRA11B; CCG trinucleotide repeat;
D O I
10.1002/ajmg.a.30090
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
We performed a prospective study of 110 patients (75 not previously published) with the 11q terminal deletion disorder (previously called Jacobsen syndrome), diagnosed by karyotype. All the patients have multiple dysmorphic features. Nearly all the patients (94%) have Paris-Trousseau syndrome characterized by thrombocytopenia and platelet dysfunction. In total, 56% of the patients have serious congenital heart defects. Cognitive function ranged from normal intelligence to moderate mental retardation. Nearly half of the patients have mild mental retardation with a characteristic neuropsychiatric profile demonstrating near normal receptive language ability, but mild to moderate impairment in expressive language. Ophthalmologic, gastrointestinal, and genitourinary problems were common, as were gross and fine motor delays. Infections of the upper respiratory system were common, but no life-threatening infections were reported. We include a molecular analysis of the deletion breakpoints in 65 patients, from which genetic "critical regions" for 14 clinical phenotypes are defined, as well as for the neuropsychiatric profiles. Based on these findings, we provide a comprehensive set of recommendations for the clinical management of patients with the 11q terminal deletion disorder. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:51 / 61
页数:11
相关论文
共 69 条
[1]  
Aalfs CM, 1999, AM J MED GENET, V86, P398, DOI 10.1002/(SICI)1096-8628(19991008)86:4<398::AID-AJMG17>3.0.CO
[2]  
2-9
[3]  
Bertoni F, 1999, GENE CHROMOSOME CANC, V26, P176, DOI 10.1002/(SICI)1098-2264(199910)26:2<176::AID-GCC11>3.0.CO
[4]  
2-3
[5]   A NEW CONGENITAL DYSMEGAKARYOPOIETIC THROMBOCYTOPENIA (PARIS-TROUSSEAU) ASSOCIATED WITH GIANT PLATELET ALPHA-GRANULES AND CHROMOSOME-11 DELETION AT 11Q23 [J].
BRETONGORIUS, J ;
FAVIER, R ;
GUICHARD, J ;
CHERIF, D ;
BERGER, R ;
DEBILI, N ;
VAINCHENKER, W ;
DOUAY, L .
BLOOD, 1995, 85 (07) :1805-1814
[6]  
Clang Daniel R., 1998, Journal of the American Osteopathic Association, V98, P551
[7]  
Connolly KC, 1999, CANCER RES, V59, P2806
[8]   The epidemiology of atopic dermatitis [J].
Daniels, J ;
Harper, J .
HOSPITAL MEDICINE, 2002, 63 (11) :649-652
[9]  
Davis M, 1996, CANCER RES, V56, P741
[10]  
FAVIER R, 1993, CR ACAD SCI III-VIE, V316, P698